Piperacillin And Tazobactam Injection, Powder, For Solution
NDC Package 72485-404-10
Package Information
Piperacillin And Tazobactam injection is the usual total daily dosage of piperacillin and tazobactam for injection for adult patients with indications other than nosocomial pneumonia is 3.375 g every six hours [totaling 13.5 g (12 g piperacillin/1.5 g tazobactam)], to be administered by intravenous infusion over 30 minutes. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Armas Pharmaceuticals Inc., this product is identified by NDC 72485-404 and is authorized under FDA application ANDA065458.
Identification & Billing
- RxCUI: 1659149 - piperacillin / tazobactam 4.5 GM Injection
- RxCUI: 1659149 - piperacillin 4000 MG / tazobactam 500 MG Injection
- RxCUI: 1659149 - piperacillin (as piperacillin sodium) 4000 MG / tazobactam (as tazobactam sodium) 500 MG Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72485 - Armas Pharmaceuticals Inc.
- 72485-404 - Piperacillin And Tazobactam
- 72485-404-10 - 10 VIAL, SINGLE-DOSE in 1 BOX / 20 mL in 1 VIAL, SINGLE-DOSE (72485-404-01)
- 72485-404 - Piperacillin And Tazobactam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72485-404-10 identifies a specific commercial package of 10 vial, single-dose in 1 box / 20 ml in 1 vial, single-dose (72485-404-01) of Piperacillin And Tazobactam, a human prescription drug labeled by Armas Pharmaceuticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for intravenous use and contains piperacillin sodium; tazobactam sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Armas Pharmaceuticals Inc. on April 14, 2022. The current certification is valid through December 31, 2026.
How is this Armas Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72485040410. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
